Using Your Nasal Spray
Nasal inhaler sprays are often used by people with allergic rhinitis (also known as hay fever) to take their intranasal corticosteroids.
Corticosteroid nasal sprays:
- are effective medicines for managing allergic rhinitis (hay fever)
- have a good safety profile and can be used every day long term
- are intended for everyday use.
Using your nasal inhaler spray properly is important. With the right technique you can be sure that the medicine is getting where it needs to, and you can reduce the chance of experiencing side-effects like nosebleeds.
These film clips have been made to show you how to use your nasal inhaler spray properly.
In each short clip, an asthma and respiratory educator demonstrates the correct use of one nasal inhaler spray.
Types of nasal inhaler sprays
These film clips demonstrate some of the common types of devices prescribed in Australia for intranasal corticosteroid sprays.
The full range of intranasal corticosteroid sprays includes: beclomethasone dipropionate (Beconase); budesonide (Budamax, Rhinocort); fluticasone furoate (Avamys); mometasone furoate (Nasonex); and triamcinolone acetonide (Telnase).
Common errors to avoid
- Forgetting to prime the inhaler spray device before using it for the first time or if you haven't used it for a while
- Skipping doses
- Holding your head in the wrong position (should be tilted forward, not back)
- Pushing the nozzle too hard or far into your nose
- Blowing your nose hard after spraying (the medicine is lost)
- Sniffing hard after spraying (the medicine ends up in your throat instead of your nose)
- Using saline sprays or irrigations after using the medicine, instead of before
Getting the most out of your nasal inhaler spray
Ask your doctor, pharmacist or asthma & respiratory educator to:
- Explain how your nasal inhaler spray should be used
- Check you are using your nasal inhaler spray properly
- Explain how to clean your nasal inhaler spray.
Resource for Health Professionals
Intranasal corticosteroid spray technique: Information paper for health professionals
This information paper provides an overview of current evidence for optimal technique when administering intranasal corticosteroid sprays, which are used in the long-term management of allergic rhinitis.
Thanks to Ms Marg Gordon, asthma & respiratory educator, and the patient who participated in the film clips.
Development of these film clips and information paper was supported by unconditional educational grants from AstraZeneca, GlaxoSmithKline Australia and MSD (Australia).
National Asthma Council Australia retained editorial control.